Michael Courtney and Lili-Li receive $108,867 grant from SynGAP Research Fund (SRF) dba Cure SYNGAP1

February 10, 2025

The SynGAP Research Fund 501(c)(3) dba Cure SYNGAP1 announced a $108,867 grant to Dr. Michael Courtney and Dr. Li-Li Li at the Turku Bioscience Centre, University of Turku, Finland, to advance their research on SYNGAP1 missense variants. Their project seeks to better understand the Read more

SynGAP Research Fund SYNGAP1

Turku Screening Unit Receives Funding to Establish Single Objective Light Sheet for longitudinal and dynamic screening of complex 3D cell systems

January 21, 2024

The Research Council of Finland awarded an infrastructure grant to the Turku Screening Unit as a part of the EU-OPENSCREEN-FINLAND consortium. The funding awarded to the Turku Screening Unit is to establish a single objective Read more

DDCB symposium on May 4th 2023

May 4, 2023

How could your research benefit from the chemical biology and drug discovery tools and infrastructure available in Finland? Find out on 4th May 2023 at the symposium held by the Drug Discovery and Chemical Biology Read more

The Turku Screening Unit is now a partner site of EU-OPENSCREEN

October 14, 2022

The Turku Sceening Unit is officially a specialised screening site of the EU-OPENSCREEN ERIC. Our specialisation include dyanamic and longitudinal imaging-based phenotypic screens of complex cell systems including, with the participation of the Zebrafish core, Read more

Turku Screening Unit applies to be a specialised screening site within EU-OPENSCREEN

March 31, 2022

Today the Turku Screening unit, in collaboration with the Zebrafish core and the Turku Proteomics core, have submitted an application to become a specialised screening site within EU-OPENSCREEN

Turku Screening Unit nominated as a specialised screening site within EU-OPENSCREEN

March 4, 2022

Turku Screening unit has been nominated as a specialised screening site within EU-OPENSCREEN by the Finnish Ministry of Education and Culture today EU-OPENSCREEN is a Europe-wide netork of screening platforms with access to EU-OPENSCREEN compound Read more